Skip Navigation LinksHome > May 2008 - Volume 20 - Issue 5 > First-time use of bevacizumab for aggressive, metastatic hep...
European Journal of Gastroenterology & Hepatology:
doi: 10.1097/MEG.0b013e3282f16411
Case Reports

First-time use of bevacizumab for aggressive, metastatic hepatocellular carcinoma in an HIV/hepatitis B virus coinfected patient: a case report

Baraboutis, Ioannis G.a; Papastamopoulos, Vassiliosa; Charitsis, Georgiosb; Lekakis, Lazaros J.c; Vaslamatzis, Michael M.c; Skoutelis, Athanasios T.a b

Collapse Box


We present a case of an HIV-1 infected patient with history of chronic hepatitis B and chronic alcohol use without cirrhosis, who presented with aggressive hepatocellular carcinoma with multiple metastases. Systemic chemotherapy combined with use of bevacizumab (anti-vascular endothelium growth factor monoclonal antibody) was without effect and the patient succumbed to his disease within few weeks. To our knowledge, this is the first report in the English literature of bevacizumab use for metastatic hepatocellular carcinoma in HIV-infected patients.

© 2008 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.